Sanofi–Translate Bio COVID-19 vaccine
Vaccine candidate against COVID-19 / From Wikipedia, the free encyclopedia
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate Bio.[2][3] The development was stopped in September 2021.[4]
Quick Facts Vaccine description, Target ...
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | mRNA |
Clinical data | |
Other names | MRT5500, VAW00001 |
Routes of administration | Intramuscular |
Legal status | |
Legal status |
|
Close